Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Perspective Therapeutics (CATX) Asset Utilization Ratio (2011 - 2023)

Perspective Therapeutics recorded quarterly Asset Utilization Ratio of 0.01 in Q4 2023, down 90.62% quarter-over-quarter from 0.06 in Q3 2023.

Perspective Therapeutics' Asset Utilization Ratio history runs 12 years deep, the most recent figure standing at 0.01 for Q4 2023.

  • In Q4 2023, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Dec 2023 stood at 0.01 (changed N/A YoY), while the FY2023 annual figure was 0.02, changed N/A from the prior year.
  • Asset Utilization Ratio came in at 0.01 for Q4 2023 at Perspective Therapeutics, down from 0.06 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.17 in Q3 2020 to a low of 0.01 in Q4 2023.
  • A 5-year average of 0.45 and a median of 0.17 in 2022 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio surged 67.59% in 2020 and tumbled 87.38% in 2021, its largest moves.
  • Perspective Therapeutics' Asset Utilization Ratio stood at 0.88 in 2019, then retreated by 4.21% to 0.84 in 2020, then plunged by 81.31% to 0.16 in 2021, then retreated by 0.36% to 0.16 in 2022, then tumbled by 96.25% to 0.01 in 2023.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.06, and 0.06 for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 0.01
Sep 30, 2023 0.06
Jun 30, 2023 0.06
Mar 31, 2023 0.10
Sep 30, 2022 0.16
Jun 30, 2022 0.17
Mar 31, 2022 0.16
Dec 31, 2021 0.16
Sep 30, 2021 0.15
Jun 30, 2021 0.14
Mar 31, 2021 0.22
Dec 31, 2020 0.84
Sep 30, 2020 1.17
Jun 30, 2020 1.10
Mar 31, 2020 1.04
Dec 31, 2019 0.88
Sep 30, 2019 0.83
Jun 30, 2019 0.73
Mar 31, 2019 0.62
Dec 31, 2018 0.53
Sep 30, 2018 0.60
Jun 30, 2018 0.75
Mar 31, 2018 0.64
Dec 31, 2017 0.54
Sep 30, 2017 0.42
Jun 30, 2017 0.36
Mar 31, 2017 0.31
Dec 31, 2016 0.28
Sep 30, 2016 0.26
Jun 30, 2016 0.25
Mar 31, 2016 0.25
Jun 30, 2014 0.16
Mar 31, 2014 0.25
Dec 31, 2013 0.53
Sep 30, 2013 0.55
Jun 30, 2013 0.61
Mar 31, 2013 0.55
Dec 31, 2012 0.51
Sep 30, 2012 0.57
Jun 30, 2012 0.67
Mar 31, 2012 0.63
Dec 31, 2011 0.66
Sep 30, 2011 0.69